Nicorette

nicotine polacrilex

Dosage Form: chewing gum, White Ice Mint
Drug Facts

Active Ingredient

Nicotine polacrilex (equal to 2mg nicotine)

Nicotine polacrilex (equal to 4mg nicotine)

Purpose

Stop smoking aid

Uses

• reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

If you are pregnant or breast feeding, only use this medicine on the advice of you health care provider.

Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Do not use

• If you continue to smoke, chew tobacco, use snuff, or use a nicotine patch or other nicotine containing products

Ask a doctor before use if you have

• a sodium-restricted diet


• heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.


• high blood pressure not controlled with medication. Nicotine can increase blood pressure.


• stomach ulcer or diabetes

Ask a doctor or a pharmacist before use if you are

• using a non-nicotine stop smoking drug


• taking prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

Stop use and ask a doctor if

• mouth, teeth or jaw problems occur


• irregular heartbeat or palpitations occur


• you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat
  

   

  
  

Keep out of reach of children and pets. Pieces of  nicotine gum may have enough nicotine to make children and pets sick. Wrap used pieces of gum in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.

Dosage and Administration 2mg

• if you are under 18 years of age, ask a doctor before use


• before using this product, read the enclosed User’s Guide for complete directions and other important information


• stop smoking completely when you begin using the gum


• if you are smoke more than 25 cigarettes a day; use 4mg nicotine gum


• if you smoke less than 25 cigarettes a day; use according to the following 12 week schedule:

Weeks 1 to 6	Weeks 7 to 9	Weeks 10 to 12
1 piece every 1 to 2 hours	1 piece every 2 to 4 hours	1 piece every 4 to 8 hours

• nicotine gum is a medicine and must be used a certain way to get the best results


• chew the gum slowly until it tingles. Then park it between your cheek and gum. When the tingle is gone, begin chewing again, until the tingle returns.


• repeat this process until most of the tingle is gone (about 30 minutes)


• do not eat or drink for 15 minutes before chewing the nicotine gum, or while chewing a piece


• to improve your chances of quitting, use at least 9 pieces per day for the first 6 weeks


• if you experience strong or frequent cravings, you may use a second piece within the hour. However, do not continuously use one piece after another since this may cause you hiccups, heartburn, nausea or other side effects.


• do not use more than 24 pieces a day


• it is important to complete treatment. Stop using the nicotine gum at the end of 12 weeks. If you still feel the need to use nicotine gum, talk to your doctor.

Dosage and Administration 4 mg

• if you are under 18 years of age, ask a doctor before use


• before using this product, read the enclosed User’s Guide for complete directions and other important information


• stop smoking completely when you begin using the gum


• if you are smoke less than 25 cigarettes a day; use 2mg nicotine gum


• if you smoke 25 or more cigarettes a day; use according to the following 12 week schedule:

Weeks 1 to 6	Weeks 7 to 9	Weeks 10 to 12
1 piece every 1 to 2 hours	1 piece every 2 to 4 hours	1 piece every 4 to 8 hours

• nicotine gum is a medicine and must be used a certain way to get the best results


• chew the gum slowly until it tingles. Then park it between your cheek and gum. When the tingle is gone, begin chewing again, until the tingle returns.


• repeat this process until most of the tingle is gone (about 30 minutes)


• do not eat or drink for 15 minutes before chewing the nicotine gum, or while chewing a piece


• to improve your chances of quitting, use at least 9 pieces per day for the first 6 weeks


• if you experience strong or frequent cravings, you may use a second piece within the hour. However, do not continuously use one piece after another since this may cause you hiccups, heartburn, nausea or other side effects.


• do not use more than 24 pieces a day


• it is important to complete treatment. Stop using the nicotine gum at the end of 12 weeks. If you still feel the need to use nicotine gum, talk to your doctor.

Inactive Ingredients

each 2 mg piece contains: calcium 94 mg, sodium 11 mg, acesulfame potassium, carnauba wax, edible ink, flavor, gum base, hypromellose, magnesium oxide, menthol, peppermint oil, polysorbate 80, sodium bicarbonate, sodium carbonate, starch, sucralose, titanium dioxide, xylitol

each 4 mg piece contains: calcium 94 mg, sodium 13 mg, acesulfame potassium, carnauba wax, D&C yellow #10 al. lake, edible ink, flavor, gum base, hypromellose, magnesium oxide, menthol, peppermint oil, polysorbate 80, sodium carbonate, starch, sucralose, titanium dioxide, xylitol

Principal Display Panel

Nicorette®

Nicotine polacrilex gum, 2mg stop smoking aid

Gum

Coated

FOR BOLD FLAVOR

White Ice Mint®

2 mg

FOR THOSE WHO SMOKE LESS THAN 25 CIGARETTES A DAY

If you smoke 25 or more cigarettes a day: use Nicorette 4mg

40 PIECES, 2mg EACH

store at 20 -25°C (68-77°F)

protect from light

To remove the gum, tear off single unit.

Push gum through foil.

Peel off backing, starting at corner with loose edge.

Questions or comments?

Call toll-free 1-800-419-4766 (English/Spanish” weekdays (9:00am – 4:30pm ET)

TO INCREASE YOUR SUCCESS IN QUITTING:

1. You must be motivated to quit.


2. Use Enough – Chew at least 9 pieces of Nicorette per day during the first six weeks.


3. Use Long Enough – Use Nicorette for the full 12 weeks.


4. Use with a support program as directed in the enclosed User’s Guide.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.com or see inside for more details.

Free Audio CD upon request.

See inside.

Nicorette  WHITE ICE MINT nicotine polacrilex  gum, chewing

Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 0135-0474 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NICOTINE (NICOTINE) NICOTINE 2 mg

Inactive Ingredients Ingredient Name Strength METHACRYLIC ACID-DIVINYL BENZENE COPOLYMER   ACESULFAME POTASSIUM   CARNAUBA WAX   HYPROMELLOSE   MAGNESIUM OXIDE   MENTHOL   POLYSORBATE 80   SODIUM BICARBONATE   PEPPERMINT OIL   SUCRALOSE   TITANIUM DIOXIDE   XYLITOL

Product Characteristics Color WHITE Score no score Shape SQUARE Size 11mm Flavor MINT (White Ice Mint) Imprint Code N2 Contains

Packaging # NDC Package Description Multilevel Packaging 1 0135-0474-01 20 PARTS In 1 BLISTER PACK None 2 0135-0474-07 40 PARTS In 1 BLISTER PACK None 3 0135-0474-02 100 PARTS In 1 BLISTER PACK None 4 0135-0474-05 160 PARTS In 1 BLISTER PACK None 5 0135-0474-03 190 PARTS In 1 BLISTER PACK None 6 0135-0474-04 210 PARTS In 1 BLISTER PACK None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NDA	NDA018612	06/29/2009

Nicorette  WHITE ICE MINT nicotine polacrilex  gum, chewing

Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 0135-0475 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NICOTINE (NICOTINE) NICOTINE 4 mg

Inactive Ingredients Ingredient Name Strength METHACRYLIC ACID-DIVINYL BENZENE COPOLYMER   ACESULFAME POTASSIUM   CARNAUBA WAX   HYPROMELLOSE   MAGNESIUM OXIDE   MENTHOL   POLYSORBATE 80   SODIUM BICARBONATE   PEPPERMINT OIL   SUCRALOSE   TITANIUM DIOXIDE   XYLITOL

Product Characteristics Color WHITE Score no score Shape SQUARE Size 11mm Flavor MINT (White Ice Mint) Imprint Code N4 Contains

Packaging # NDC Package Description Multilevel Packaging 1 0135-0475-01 20 PARTS In 1 BLISTER PACK None 2 0135-0475-07 40 PARTS In 1 BLISTER PACK None 3 0135-0475-02 100 PARTS In 1 BLISTER PACK None 4 0135-0475-05 160 PARTS In 1 BLISTER PACK None 5 0135-0475-03 190 PARTS In 1 BLISTER PACK None 6 0135-0475-04 210 PARTS In 1 BLISTER PACK None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NDA	NDA020066	06/29/2009

Labeler - GlaxoSmithKline Consumer Healthcare LP (091328625)

Revised: 06/2009GlaxoSmithKline Consumer Healthcare LP

More Nicorette resources

• Nicorette Side Effects (in more detail)
• Nicorette Dosage
• Nicorette Use in Pregnancy & Breastfeeding
• Nicorette Drug Interactions
• Nicorette Support Group
• 4 Reviews for Nicorette - Add your own review/rating

• Nicorette Consumer Overview


• Nicorette Gum MedFacts Consumer Leaflet (Wolters Kluwer)


• nicotine Inhalation, oral/nebulization Advanced Consumer (Micromedex) - Includes Dosage Information


• Nicotine Monograph (AHFS DI)


• Nicotine Professional Patient Advice (Wolters Kluwer)


• Commit Lozenges MedFacts Consumer Leaflet (Wolters Kluwer)


• Habitrol Advanced Consumer (Micromedex) - Includes Dosage Information


• Nicotrol Inhaler MedFacts Consumer Leaflet (Wolters Kluwer)


• Nicotrol NS Spray MedFacts Consumer Leaflet (Wolters Kluwer)


• Nicotrol NS Advanced Consumer (Micromedex) - Includes Dosage Information

Compare Nicorette with other medications

• Smoking Cessation

methyl aminolevulinate topical

Generic Name: methyl aminolevulinate (topical) (METH il a MEE noe LEV ue LIN ate)

Brand Names: Metvixia

What is methyl aminolevulinate?

Methyl aminolevulinate makes your skin more sensitive to light. It works by causing a reaction with light that can destroy certain types of diseased skin cells.

Methyl aminolevulinate topical (for the skin) is used in combination with red light therapy to treat a skin condition called actinic keratosis of the face and scalp.

Methyl aminolevulinate may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about methyl aminolevulinate?

You should not use this medication if you are allergic to methyl aminolevulinate, porphyrins, peanuts or almonds, or if your skin is especially sensitive to light.

Before you are treated with methyl aminolevulinate, tell your doctor about all of your medical conditions. Also tell your doctor about all other medications you use, especially drugs that can make your skin more sensitive to sunlight, such as certain antibiotics, heart or blood pressure medications, diuretics (water pills), sulfa drugs, oral diabetes medications, or NSAID pain or arthritis medicines.

Methyl aminolevulinate is applied by a healthcare provider in a clinic setting. For at least 48 hours after your treatment, avoid exposing treated skin to sunlight, sunlamps, tanning beds, or other bright lights. Sunscreen is not effective enough to protect treated skin from harm caused by bring light during this time. Wear protective clothing whenever you are outdoors. Call your doctor at once if you have severe stinging, burning, redness, oozing, or swelling of treated skin areas, especially if you have these effects for longer than 3 weeks after treatment.

It may take several weeks before you notice improvement in your skin condition. Your doctor will need to check your treated skin 3 months after the end of your last treatment with methyl aminolevulinate.

Your skin lesions may need to be treated more than once, and they may come back after treatment. Talk to your doctor about the number of treatments needed to treat your condition.

What should I discuss with my health care provider before taking methyl aminolevulinate?

You should not use this medication if you are allergic to methyl aminolevulinate, or if you have:

• 
  

  an allergy to peanuts or almonds;

  
  


• 
  

  an allergy to porphyrins; or

  
  


• 
  

  if your skin is especially sensitive to light.

  
  

Before you are treated with methyl aminolevulinate, tell your doctor about all of your medical conditions.

FDA pregnancy category C. It is not known whether methyl aminolevulinate is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether methyl aminolevulinate passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How is methyl aminolevulinate used?

Methyl aminolevulinate topical is a cream that is applied to actinic keratosis skin lesions prior to red light treatment. Your doctor, nurse, or other healthcare provider will prepare your skin and apply this medication in a clinic setting.

Prior to application of methyl aminolevulinate, your skin lesions will be gently scraped to remove any scales or crusting. After the medication is applied, your caregiver will cover the treatment area with a bandage. You will need to leave this bandage in place for 3 hours.

During this 3-hour period, avoid exposure to cold temperatures and sunlight or bright indoor lights. Wear a wide-brimmed hat if you must be outdoors during this time.

After your bandaging is removed, any excess medication will be removed with a saline solution. You will then be ready to receive the light treatment.

You will be given eye-wear to protect your eyes during red light treatment.

You may feel a slight stinging or burning during light therapy. Tell your caregivers if you have any type of severe discomfort.

Methyl aminolevulinate and red light therapy is usually given in two sessions one week apart. Your treatment schedule may be different. Follow your doctor's instructions.

It may take several weeks before you notice improvement in your skin condition. Your doctor will need to check your treated skin 3 months after the end of your last treatment with methyl aminolevulinate.

Your skin lesions may need to be treated more than once, and they may come back after treatment. Talk to your doctor about the number of treatments needed to treat your condition.

What happens if I miss a dose?

Since methyl aminolevulinate is applied only when needed prior to red light therapy, you will not be on a dosing schedule.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

Symptoms of a methyl aminolevulinate overdose are not known.

What should I avoid while taking methyl aminolevulinate?

Tell your caregivers right away if any of this medication gets into your eyes, mouth, or nose. Avoid touching the treated skin areas after methyl aminolevulinate cream has been applied to them. Special gloves must be worn by the healthcare provider while applying this medication, and you should not allow your own fingers to come into contact with the cream on your skin. For at least 48 hours after your treatment, avoid exposing treated skin to sunlight, sunlamps, tanning beds, or other bright lights. Sunscreen is not effective enough to protect treated skin from harm caused by bring light during this time. Wear protective clothing whenever you are outdoors.

Even if you do not receive the light therapy portion of your treatment, you must still protect your skin from light for 48 hours after the cream was applied.

Methyl aminolevulinate side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have severe stinging, burning, redness, oozing, or swelling of treated skin areas, especially if you have these effects for longer than 3 weeks after treatment.

Less serious side effects may include:

• 
  

  mild skin redness, warmth, burning, or swelling;

  
  


• 
  

  puffy eyes;

  
  


• 
  

  slight pain; or

  
  


• 
  

  itching, peeling, scabs or crusting of treated skin.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect.

Methyl aminolevulinate Dosing Information

Usual Adult Dose for Keratosis:

Non-hyperkeratotic, nonpigmented actinic keratoses of the face and scalp in immunocompetent patients: Apply directly on lesion(s), up to a total of 1 gram (half tube) per each treatment session. Two sessions one week apart should be administered. Cream application should be followed by photoactivation with Aktilite CL 128 lamp red light illumination.

Prior to cream application, a small dermal curette should be used to remove scales and crusts and to roughen the surface of the lesion(s). An approximately 1 mm-thick layer of cream should be applied with a spatula to each lesion and the surrounding 5 mm of normal skin. The application area should then be covered with an occlusive, nonabsorbent dressing for 3 hours (2.5 to 4 hours). Multiple lesions may be treated during the same session, up to an area of 80 X 180 mm (the area of illumination).

Following removal of the occlusive dressing, clean the area with saline and gauze before beginning Aktilite red light treatment. The light dose to be used is 37 J/cm2, and the lamp should be placed 50 to 80 mm (2 to 3.2 inches) from the skin. The required illumination time (7 to 10 minutes) is calculated automatically. Both the patient and operator should wear appropriate eye protection during illumination and avoid staring into the beam. The illumination stops automatically.

If Aktilite red light treatment is interrupted or stopped for any reason, it may be restarted. If the patient cannot have the red light treatment during the prescribed period after application, the cream should be rinsed off and the patient should protect the exposed area from sunlight and prolonged or intense light for at least 48 hours.

What other drugs will affect methyl aminolevulinate?

Tell your doctor about all other medications you use, especially drugs that can make your skin more sensitive to sunlight, such as:

• 
  

  amiodarone (Cordarone, Pacerone);

  
  


• 
  

  diabetes medications you take by mouth;

  
  


• 
  

  diltiazem (Tiazac, Cartia, Cardizem);

  
  


• 
  

  furosemide (Lasix);

  
  


• 
  

  porfimer (Photofrin);

  
  


• 
  

  quinidine (Quinaglute, Quinidex, Quin-Release);

  
  


• 
  

  tacrolimus (Prograf);

  
  


• 
  

  verteporfin (Visudyne);

  
  


• 
  

  an ACE inhibitor such as benazepril (Lotensin), captopril (Capoten), fosinopril (Monopril), enalapril (Vasotec), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), or trandolapril (Mavik);

  
  


• 
  

  an antibiotic such as ciprofloxacin (Cipro), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), levofloxacin (Levaquin), ofloxacin (Floxin), norfloxacin (Noroxin), tetracycline (Brodspec, Panmycin, Sumycin, Tetracap);

  
  


• 
  

  a diuretic (water pill) such as hydrochlorothiazide (HCTZ), contained in Aldoril, Atacand, Capozide, HydroDiuril, Hyzaar, Lopressor, Lotensin, Moduretic, Monopril, Tekturna, Teveten, Vaseretic, Zestoretic, Ziac, and others;

  
  


• 
  

  an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Cataflam, Voltaren), etodolac (Lodine), indomethacin (Indocin), ketoprofen (Orudis), and others; or

  
  


• 
  

  a sulfa drug (such as Bactrim, Septra, SMX-TMP, and others).

  
  

This list is not complete and there may be other drugs that can interact with methyl aminolevulinate. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More methyl aminolevulinate resources

• Methyl aminolevulinate Side Effects (in more detail)
• Methyl aminolevulinate Dosage
• Methyl aminolevulinate Use in Pregnancy & Breastfeeding
• Methyl aminolevulinate Drug Interactions
• Methyl aminolevulinate Support Group
• 0 Reviews for Methyl aminolevulinate - Add your own review/rating

• Metvixia Prescribing Information (FDA)


• Metvixia Advanced Consumer (Micromedex) - Includes Dosage Information


• Metvixia Cream MedFacts Consumer Leaflet (Wolters Kluwer)


• Metvixia Consumer Overview

Compare methyl aminolevulinate with other medications

• Actinic Keratosis

Where can I get more information?

• Your doctor or pharmacist can provide more information about methyl aminolevulinate.

See also: methyl aminolevulinate side effects (in more detail)

NataFort Tablets

Dosage Form: tablet
NataFort®

PRENATAL MULTIVITAMIN TABLET WITH IRON

NataFort Tablets Description

NataFort® is a prescription prenatal/postnatal multivitamin/mineral supplement. The tablet is white, coated, and oval in shape, and is debossed "N1" on one side and is blank on the other.

Each prenatal tablet contains:
Vitamin C (Ascorbic acid)	120 mg
Vitamin D3 (Cholecalciferol)	400 IU
Vitamin E (dl-alpha tocoperyl acetate)	11 IU
Thiamin (Vitamin B1)	2 mg
Riboflavin (Vitamin B2)	3 mg
Niacinamide (Vitamin B3)	20 mg
Vitamin B6 (Pyridoxine HCl)	10 mg
Folic Acid	1 mg
Vitamin B12 (Cyanocobalamin)	12 mcg
Iron (Ferrous fumarate, carbonyl iron)	60 mg

INDICATIONS

NataFort® is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

Contraindications

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

Warning

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

Precautions

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

Adverse Reactions

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

NataFort Tablets Dosage and Administration

One tablet daily or as directed by a physician.

Store at controlled room temperature.

NOTICE: Contact with moisture can discolor or erode the tablet.

How is NataFort Tablets Supplied

Bottles of 90 tablets each - NDC 0178-0716-90.

US Patent 6,521,247

MISSION PHARMACAL COMPANY

San Antonio, TX USA 78230 1355

Copyright © 2011 Mission Pharmacal Company.

All rights reserved.

L071690 C01 Rev 005110

PRINCIPAL DISPLAY PANEL - 90 Tablet Bottle Label

NDC 0178-0716-90

NataFort®

PRENATAL MULTIVITAMIN TABLET WITH IRON

For use before, during and after pregnancy

90 Tablets

Rx Only

Mission®

PHARMACAL

US Patent 6,521,247

NATAFORT  ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, and iron  tablet

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0178-0716 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Ascorbic acid (Ascorbic acid) Ascorbic acid 120 mg Cholecalciferol (Cholecalciferol) Cholecalciferol 400 [iU] .alpha.-tocopherol acetate, dl- (.alpha.-tocopherol acetate, dl-) .alpha.-tocopherol acetate, dl- 11 [iU] Thiamine mononitrate (Thiamine) Thiamine mononitrate 2 mg Riboflavin (Riboflavin) Riboflavin 3 mg Niacinamide (Niacinamide) Niacinamide 20 mg Pyridoxine Hydrochloride (Pyridoxine) Pyridoxine Hydrochloride 10 mg Folic Acid (Folic Acid) Folic Acid 1 mg Cyanocobalamin (Cyanocobalamin) Cyanocobalamin 12 ug Iron (Iron) Iron 60 mg

Inactive Ingredients Ingredient Name Strength polyethylene glycols   calcium carbonate   povidone   cellulose, microcrystalline   croscarmellose sodium   titanium dioxide   magnesium silicate   vitamin a palmitate   magnesium stearate   ethyl vanillin   Dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer

Product Characteristics Color WHITE Score no score Shape OVAL Size 14mm Flavor Imprint Code N1 Contains

Packaging # NDC Package Description Multilevel Packaging 1 0178-0716-90 90 TABLET In 1 BOTTLE None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug other		08/25/2011

Labeler - Mission Pharmacal Company (008117095)

Establishment
Name	Address	ID/FEI	Operations
Mission Pharmacal Company		927726893	MANUFACTURE

Revised: 08/2011Mission Pharmacal Company

More NataFort Tablets resources

• NataFort Tablets Use in Pregnancy & Breastfeeding
• Drug Images
• NataFort Tablets Drug Interactions
• NataFort Tablets Support Group
• 21 Reviews for NataForts - Add your own review/rating

Compare NataFort Tablets with other medications

• Vitamin/Mineral Supplementation during Pregnancy/Lactation

Azimakrol

Azimakrol may be available in the countries listed below.

Ingredient matches for Azimakrol

Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azimakrol in the following countries:

• Venezuela

International Drug Name Search

Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets

Pronunciation: klor-fen-IR-ah-meen/fen-ill-EF-rin /fen-ill-tole-OX-a-meen
Generic Name: Chlorpheniramine/Phenylephrine/Phenyltoloxamine
Brand Name: Examples include Nalex-A and Rhinacon A

Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets are used for:

Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets are an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.

Do NOT use Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets if:

• you are allergic to any ingredient in Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets:

Some medical conditions may interact with Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of asthma; lung problems (eg, emphysema); adrenal gland problems (eg, adrenal gland tumor); heart problems; high blood pressure; diabetes; heart blood vessel problems; stroke; glaucoma; a blockage of your bladder, stomach, or intestines; ulcers; trouble urinating; an enlarged prostate or other prostate problems; seizures; or an overactive thyroid

Some MEDICINES MAY INTERACT with Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), sodium oxybate (GHB ), or tricyclic antidepressants (eg, amitriptyline) because side effects of Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets may be increased


• Digoxin or droxidopa because risk of irregular heartbeat or heart attack may be increased


• Bromocriptine or hydantoins (eg, phenytoin) because side effects may be increased by Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because effectiveness may be decreased by Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets:

Use Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets may be taken with or without food.


• Swallow Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets whole. Do not break, crush, or chew before swallowing.


• If you miss a dose of Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets.

Important safety information:

• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets may cause dizziness, drowsiness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets. Using Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Do not take diet or appetite control medicines while you are taking Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets without checking with your doctor.


• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets contains phenylephrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains phenylephrine. If it does or if you are uncertain, contact your doctor or pharmacist.


• Do NOT exceed the recommended dose or take Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets for longer than prescribed without checking with your doctor.


• If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.


• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets. Use a sunscreen or protective clothing if you must be outside for a prolonged period.


• If you are scheduled for allergy skin testing, do not take Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets for several days before the test because it may decrease your response to the skin tests.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets.


• Use Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets with caution in the ELDERLY because they may be more sensitive to its effects.


• Caution is advised when using Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets, discuss with your doctor the benefits and risks of using Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets during pregnancy. It is unknown if Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets are excreted in breast milk. Do not breast-feed while taking Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets.

Possible side effects of Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Chlorpheniramine/Phenylephrine/Phenyltoloxamine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org ), or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets:

Store Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Chlorpheniramine/Phenylephrine/Phenyltoloxamine Controlled-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Chlorpheniramine/Phenylephrine/Phenyltoloxamine resources

• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Side Effects (in more detail)
• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Use in Pregnancy & Breastfeeding
• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Drug Interactions
• Chlorpheniramine/Phenylephrine/Phenyltoloxamine Support Group
• 0 Reviews for Chlorpheniramine/Phenylephrine/Phenyltoloxamine - Add your own review/rating

Compare Chlorpheniramine/Phenylephrine/Phenyltoloxamine with other medications

• Cold Symptoms
• Nasal Congestion
• Sinus Symptoms

Natachew

Generic Name: prenatal multivitamins (PRE nay tal VYE ta mins)

Brand Names: Advance Care Plus, Bright Beginnings, Cavan Folate, Cavan One, Cavan-Heme OB, Cenogen Ultra, CitraNatal Rx, Co Natal FA, Complete Natal DHA, Complete-RF, CompleteNate, Concept OB, Docosavit, Dualvit OB, Duet, Edge OB, Elite OB 400, Femecal OB, Folbecal, Folcaps Care One, Folivan-OB, Foltabs, Gesticare, Icar Prenatal, Icare Prenatal Rx, Inatal Advance, Infanate DHA, Kolnatal DHA, Lactocal-F, Marnatal-F, Maternity, Maxinate, Mission Prenatal, Multi-Nate 30, Multinatal Plus, Nata 29 Prenatal, Natachew, Natafort, Natelle, Neevo, Nestabs, Nexa Select with DHA, Novanatal, NovaStart, O-Cal Prenatal, OB Complete, OB Natal One, Ob-20, Obtrex DHA, OptiNate, Paire OB Plus DHA, PNV Select, PNV-Total, PR Natal 400, Pre-H-Cal, Precare, PreferaOB, Premesis Rx, PrenaCare, PrenaFirst, PrenaPlus, Prenatabs OBN, Prenatabs Rx, Prenatal 1 Plus 1, Prenatal Elite, Prenatal Multivitamins, Prenatal Plus, Prenatal S, Prenatal-U, Prenate Advanced Formula, Prenate DHA, Prenate Elite, Prenavite FC, PreNexa, PreQue 10, Previte Rx, PrimaCare, Pruet DHA, RE OB Plus DHA, Renate, RightStep, Rovin-NV, Se-Care, Se-Natal One, Se-Plete DHA, Se-Tan DHA, Select-OB, Seton ET, Strongstart, Stuart Prenatal with Beta Carotene, Tandem OB, Taron-BC, Tri Rx, TriAdvance, TriCare, Trimesis Rx, Trinate, Triveen-PRx RNF, UltimateCare Advance, Ultra-Natal, Vemavite PRX 2, VeNatal FA, Verotin-BY, Verotin-GR, Vinacal OR, Vinatal Forte, Vinate Advanced (New Formula), Vinate AZ, Vinate Care, Vinate Good Start, Vinate II (New Formula), Vinate III, Vinate One, Vitafol-OB, VitaNatal OB plus DHA, Vitaphil, Vitaphil Aide, Vitaphil Plus DHA, Vitaspire, Viva DHA, Vol-Nate, Vol-Plus, Vol-Tab Rx, Vynatal F.A., Zatean-CH, Zatean-PN

What are Natachew (prenatal multivitamins)?

There are many brands and forms of prenatal vitamin available and not all brands are listed on this leaflet.

Prenatal vitamins are a combination of many different vitamins that are normally found in foods and other natural sources.

Prenatal vitamins are used to provide the additional vitamins needed during pregnancy. Minerals may also be contained in prenatal multivitamins.

Prenatal vitamins may also be used for purposes not listed in this medication guide.

What is the most important information I should know about prenatal vitamins?

There are many brands and forms of prenatal vitamin available and not all brands are listed on this leaflet.

Never take more than the recommended dose of a multivitamin. Avoid taking any other multivitamin product within 2 hours before or after you take your prenatal vitamins. Taking similar vitamin products together at the same time can result in a vitamin overdose or serious side effects.

Many multivitamin products also contain minerals such as calcium, iron, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of vitamins A, D, E, or K can cause serious or life-threatening side effects and can also harm your unborn baby. Certain minerals contained in a prenatal multivitamin may also cause serious overdose symptoms or harm to the baby if you take too much.

Overdose symptoms may include stomach pain, vomiting, diarrhea, constipation, loss of appetite, hair loss, peeling skin, tingly feeling in or around your mouth, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine, pale skin, and easy bruising or bleeding.

Do not take this medication with milk, other dairy products, calcium supplements, or antacids that contain calcium. Calcium may make it harder for your body to absorb certain ingredients of the multivitamin.

What should I discuss with my healthcare provider before taking prenatal vitamins?

Many vitamins can cause serious or life-threatening side effects if taken in large doses. Do not take more of this medication than directed on the label or prescribed by your doctor.

Before taking prenatal vitamins, tell your doctor about all of your medical conditions.

You may need to continue taking prenatal vitamins if you breast-feed your baby. Ask your doctor about taking this medication while breast-feeding.

How should I take prenatal vitamins?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Never take more than the recommended dose of prenatal vitamins.

Many multivitamin products also contain minerals such as calcium, iron, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.

Take your prenatal vitamin with a full glass of water.

Swallow the regular tablet or capsule whole. Do not break, chew, crush, or open it.

The chewable tablet must be chewed or allowed to dissolve in your mouth before swallowing. You may also allow the chewable tablet to dissolve in drinking water, fruit juice, or infant formula (but not milk or other dairy products). Drink this mixture right away.

Use prenatal vitamins regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

Store at room temperature away from moisture and heat. Keep prenatal vitamins in their original container. Storing vitamins in a glass container can ruin the medication.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of vitamins A, D, E, or K can cause serious or life-threatening side effects and can also harm your unborn baby. Certain minerals contained in a prenatal multivitamin may also cause serious overdose symptoms or harm to the baby if you take too much.

Overdose symptoms may include stomach pain, vomiting, diarrhea, constipation, loss of appetite, hair loss, peeling skin, tingly feeling in or around your mouth, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine, pale skin, and easy bruising or bleeding.

What should I avoid while taking prenatal vitamins?

Avoid taking any other multivitamin product within 2 hours before or after you take your prenatal vitamins. Taking similar vitamin products together at the same time can result in a vitamin overdose or serious side effects.

Avoid the regular use of salt substitutes in your diet if your multivitamin contains potassium. If you are on a low-salt diet, ask your doctor before taking a vitamin or mineral supplement.

Do not take this medication with milk, other dairy products, calcium supplements, or antacids that contain calcium. Calcium may make it harder for your body to absorb certain ingredients of the prenatal vitamin.

Prenatal vitamins side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

When taken as directed, prenatal vitamins are not expected to cause serious side effects. Less serious side effects may include:

• 
  

  upset stomach;

  
  


• 
  

  headache; or

  
  


• 
  

  unusual or unpleasant taste in your mouth.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect prenatal vitamins?

Vitamin and mineral supplements can interact with certain medications, or affect how medications work in your body. Before taking a prenatal vitamin, tell your doctor if you also use:

• 
  

  diuretics (water pills);

  
  


• 
  

  heart or blood pressure medications;

  
  


• 
  

  tretinoin (Vesanoid);

  
  


• 
  

  isotretinoin (Accutane, Amnesteen, Clavaris, Sotret);

  
  


• 
  

  trimethoprim and sulfamethoxazole (Cotrim, Bactrim, Gantanol, Gantrisin, Septra, TMP/SMX); or

  
  


• 
  

  an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn, Naprelan, Treximet), celecoxib (Celebrex), diclofenac (Cataflam, Voltaren), indomethacin (Indocin), meloxicam (Mobic), and others.

  
  

This list is not complete and other drugs may interact with prenatal vitamins. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More Natachew resources

• Natachew Use in Pregnancy & Breastfeeding
• Natachew Drug Interactions
• Natachew Support Group
• 0 Reviews for Natachew - Add your own review/rating

• Cal-Nate MedFacts Consumer Leaflet (Wolters Kluwer)


• CareNatal DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• CitraNatal 90 DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• CitraNatal Assure Prescribing Information (FDA)


• CitraNatal Harmony Prescribing Information (FDA)


• Concept DHA Prescribing Information (FDA)


• Docosavit Prescribing Information (FDA)


• Duet DHA with Ferrazone MedFacts Consumer Leaflet (Wolters Kluwer)


• Folbecal MedFacts Consumer Leaflet (Wolters Kluwer)


• Folcal DHA Prescribing Information (FDA)


• Folcaps Care One Prescribing Information (FDA)


• Gesticare DHA Prescribing Information (FDA)


• Gesticare DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• Inatal Advance Prescribing Information (FDA)


• Inatal Ultra Prescribing Information (FDA)


• Multi-Nate DHA Prescribing Information (FDA)


• Multi-Nate DHA Extra Prescribing Information (FDA)


• MultiNatal Plus MedFacts Consumer Leaflet (Wolters Kluwer)


• Natelle One Prescribing Information (FDA)


• Neevo Caplets MedFacts Consumer Leaflet (Wolters Kluwer)


• Neevo DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• OB Complete 400 MedFacts Consumer Leaflet (Wolters Kluwer)


• Paire OB Plus DHA Prescribing Information (FDA)


• PreNexa MedFacts Consumer Leaflet (Wolters Kluwer)


• PreNexa Prescribing Information (FDA)


• PreferaOB Prescribing Information (FDA)


• Prenatal Plus Prescribing Information (FDA)


• Prenatal Plus Iron Prescribing Information (FDA)


• Prenate Elite Prescribing Information (FDA)


• Prenate Elite MedFacts Consumer Leaflet (Wolters Kluwer)


• Prenate Elite tablets


• Prenate Essential Prescribing Information (FDA)


• PrimaCare Advantage MedFacts Consumer Leaflet (Wolters Kluwer)


• PrimaCare ONE capsules


• PrimaCare One MedFacts Consumer Leaflet (Wolters Kluwer)


• Renate DHA Prescribing Information (FDA)


• Se-Natal 19 Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Se-Natal 19 Prescribing Information (FDA)


• Tandem DHA Prescribing Information (FDA)


• Tandem OB Prescribing Information (FDA)


• TriAdvance Prescribing Information (FDA)


• Triveen-One MedFacts Consumer Leaflet (Wolters Kluwer)


• Triveen-PRx RNF Prescribing Information (FDA)


• UltimateCare ONE NF Prescribing Information (FDA)


• Ultra NatalCare MedFacts Consumer Leaflet (Wolters Kluwer)


• Vinate AZ Prescribing Information (FDA)


• Vitafol-One MedFacts Consumer Leaflet (Wolters Kluwer)


• Zatean-CH Prescribing Information (FDA)

Compare Natachew with other medications

• Vitamin/Mineral Supplementation during Pregnancy/Lactation

Where can I get more information?

• Your pharmacist can provide more information about prenatal vitamins.

Vioform Hydrocortisone

Vioform Hydrocortisone may be available in the countries listed below.

Ingredient matches for Vioform Hydrocortisone

Hydrocortisone

Hydrocortisone is reported as an ingredient of Vioform Hydrocortisone in the following countries:

• Canada

International Drug Name Search

NasoGel Gel

Pronunciation: SAY-leen
Generic Name: Saline
Brand Name: NasoGel

NasoGel Gel is used for:

Treating dry or irritated nasal passages caused by colds, allergies, low humidity, or overuse of decongestant nose spray.

NasoGel Gel is a moisturizing salt gel. It works by soothing and moisturizing dry nasal passages.

Do NOT use NasoGel Gel if:

• you are allergic to any ingredient in NasoGel Gel

Contact your doctor or health care provider right away if this applies to you.

Before using NasoGel Gel:

Some medical conditions may interact with NasoGel Gel. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with NasoGel Gel. However, no specific interactions are known at this time.

Ask your health care provider if NasoGel Gel may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use NasoGel Gel:

Use NasoGel Gel as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Apply a small amount of NasoGel Gel to the inside of each nostril as needed for dryness.


• You may use a clean cotton swab to apply NasoGel Gel, unless otherwise directed by your doctor.


• If you miss a dose of NasoGel Gel, use the dose when you remember and continue to use NasoGel Gel as directed by your doctor or the package labeling.

Ask your health care provider any questions you may have about how to use NasoGel Gel.

Important safety information:

• NasoGel Gel is for the nose. Do not use it for dryness in the mouth.


• If your symptoms do not improve or if they become worse, check with your doctor.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using NasoGel Gel while you are pregnant. It is not known if NasoGel Gel is found in breast milk after topical use. If you are or will be breast-feeding while you use NasoGel Gel, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of NasoGel Gel:

All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with the proper use of NasoGel Gel. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: NasoGel side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of NasoGel Gel:

Store NasoGel Gel at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store in a cool, dry place away from heat, moisture, and light. Do not freeze. Do not store in the bathroom. Keep NasoGel Gel out of the reach of children and away from pets.

General information:

• If you have any questions about NasoGel Gel, please talk with your doctor, pharmacist, or other health care provider.


• NasoGel Gel is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about NasoGel Gel. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More NasoGel resources

• NasoGel Side Effects (in more detail)
• NasoGel Use in Pregnancy & Breastfeeding
• NasoGel Support Group
• 0 Reviews for NasoGel - Add your own review/rating

Compare NasoGel with other medications

• Nasal Congestion

Viravan-P Suspension

Pronunciation: SOO-doe-e-FED-rin/pir-IL-a-meen
Generic Name: Pseudoephedrine/Pyrilamine
Brand Name: Viravan-P

Viravan-P Suspension is used for:

Relieving symptoms of sinus congestion, sinus pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Viravan-P Suspension is an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, relieving congestion and pressure.

Do NOT use Viravan-P Suspension if:

• you are allergic to any ingredient in Viravan-P Suspension


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems


• you are unable to urinate or are having an asthma attack


• you take droxidopa, sodium oxybate (GHB), or if you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Viravan-P Suspension:

Some medical conditions may interact with Viravan-P Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of adrenal gland problems (eg, adrenal gland tumor); heart problems (eg, cor pulmonale; fast, slow, or irregular heartbeat; heart disease); high blood pressure; diabetes; blood vessel problems; stroke; glaucoma or increased pressure in the eye; seizures; or thyroid problems


• if you have a history of asthma or other breathing problems, chronic cough, lung problems (eg, chronic bronchitis, emphysema), chronic obstructive pulmonary disease (COPD), or sleep apnea


• if you have a blockage of your bladder, stomach, or bowels; ulcers; trouble sleeping; trouble urinating; an enlarged prostate or other prostate problems

Some MEDICINES MAY INTERACT with Viravan-P Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Beta-blockers (eg, propranolol), furazolidone, linezolid, MAOIs (eg, phenelzine), sodium oxybate (GHB), tricyclic antidepressants (eg, amitriptyline), or urinary alkalinizers (eg, sodium bicarbonate) because they may increase the risk of Viravan-P Suspension's side effects


• Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by Viravan-P Suspension


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Viravan-P Suspension

This may not be a complete list of all interactions that may occur. Ask your health care provider if Viravan-P Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Viravan-P Suspension:

Use Viravan-P Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Viravan-P Suspension by mouth with or without food.


• Shake well before each use.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Viravan-P Suspension and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Viravan-P Suspension.

Important safety information:

• Viravan-P Suspension may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Viravan-P Suspension with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Viravan-P Suspension; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Do not take diet or appetite control medicines while you are taking Viravan-P Suspension without checking with your doctor.


• Before you start any new medicine, check the label to see if it has a decongestant or antihistamine in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 5 to 7 days or if they get worse, check with your doctor.


• Viravan-P Suspension may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Viravan-P Suspension. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Viravan-P Suspension may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Viravan-P Suspension for a few days before the tests.


• Tell your doctor or dentist that you take Viravan-P Suspension before you receive any medical or dental care, emergency care, or surgery.


• Use Viravan-P Suspension with caution in the ELDERLY; they may be more sensitive to its effects, especially confusion, dizziness, drowsiness, dry mouth, excitability, low blood pressure, and trouble urinating.


• Caution is advised when using Viravan-P Suspension in CHILDREN; they may be more sensitive to its effects, especially excitability.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Viravan-P Suspension while you are pregnant. Do not take Viravan-P Suspension in the third trimester of pregnancy. Viravan-P Suspension may be found in breast milk. Do not breast-feed while taking Viravan-P Suspension.

Possible side effects of Viravan-P Suspension:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred vision or other vision changes; confusion; difficulty urinating or inability to urinate; fast or irregular heartbeat; fever, chills, or persistent sore throat; hallucinations; mood or mental changes; persistent trouble sleeping; restlessness; seizures; severe dizziness, drowsiness, lightheadedness, or headache; tremor.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Viravan-P side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; ringing in the ears; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular breathing; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Viravan-P Suspension:

Store Viravan-P Suspension at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Viravan-P Suspension out of the reach of children and away from pets.

General information:

• If you have any questions about Viravan-P Suspension, please talk with your doctor, pharmacist, or other health care provider.


• Viravan-P Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Viravan-P Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Viravan-P resources

• Viravan-P Side Effects (in more detail)
• Viravan-P Use in Pregnancy & Breastfeeding
• Viravan-P Drug Interactions
• Viravan-P Support Group
• 0 Reviews for Viravan-P - Add your own review/rating

Compare Viravan-P with other medications

• Nasal Congestion